NextCure, Inc.
NXTC
$0.3612
$0.02647.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.80% | 19.31% | 13.75% | -6.28% | 16.38% |
| Total Depreciation and Amortization | -18.20% | -26.00% | -26.52% | -17.71% | -18.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.91% | -26.98% | -31.25% | 43.98% | -43.92% |
| Change in Net Operating Assets | 121.70% | -55.84% | 3,518.56% | 119.71% | -71.71% |
| Cash from Operations | 34.69% | 10.36% | 33.71% | 14.70% | -19.23% |
| Capital Expenditure | 361.54% | 39.07% | -7.50% | 85.08% | 98.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.84% | 75.02% | 78.27% | -2.46% | -21.71% |
| Cash from Investing | 67.18% | 78.12% | 81.22% | -1.33% | -6.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -49.30% | -- | 27.71% | -- | 16.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.30% | -- | 27.71% | -- | 16.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.39% | 374.16% | 131.31% | 57.82% | -45.63% |